Organization Profile

You just read:

Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase II Pancreatic Cancer Study

News provided by

Oncolytics Biotech Inc.

Jul 08, 2014, 06:30 ET